Summary & Overview
CPT 20610: Arthrocentesis or Injection of Major Joint or Bursa
CPT 20610 represents arthrocentesis, aspiration and/or injection of a major joint or bursa, a common procedure in musculoskeletal care used for diagnostic sampling and therapeutic delivery. Nationally, this code is widely used across orthopedics, sports medicine, primary care, and emergency medicine, reflecting its role in managing joint pain, effusion, and inflammatory or degenerative conditions. The code is relevant for clinicians, billing teams, and payers due to its frequency, variable site-of-service utilization, and potential documentation and billing nuances.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and billing practices can vary by payer and setting, particularly between office and outpatient hospital locations. Readers will find concise benchmarks for coding and site-of-service patterns, an overview of common modifiers and billing considerations, and clinical context linking typical indications to relevant ICD-10 diagnoses. The publication also summarizes related procedure coding and differences when ultrasound guidance or recorded documentation is involved.
This summary is intended to inform clinicians and administrative staff about the clinical scope of CPT 20610, typical service settings, payer coverage landscape, and practical considerations for accurate coding and claims submission.
CPT Code Overview
CPT 20610 describes arthrocentesis, aspiration and/or injection of a major joint or bursa (for example, shoulder, hip, knee joint, subacromial bursa). This procedure involves removal of synovial fluid and/or administration of medication into a large joint or bursa to diagnose or treat joint pathology.
Service type: Musculoskeletal system—arthrocentesis/injection procedures
Typical site of service: Office (POS 11) or Outpatient Hospital (POS 19/22), depending on setting
Clinical & Coding Specifications
A 68-year-old patient with symptomatic knee osteoarthritis presents to an outpatient orthopedic clinic with increasing joint pain, swelling, and reduced range of motion. After history, focused musculoskeletal exam, and review of prior imaging, the clinician performs an in-office aspiration of the knee joint to relieve effusion and obtain synovial fluid for analysis, followed by an intra-articular corticosteroid injection for pain control. The procedure is performed in the office (POS 11) or outpatient hospital setting (POS 19/22) depending on facility registration and resources. Pre-procedure documentation includes indication, informed consent, review of allergies, and laterality. Post-procedure documentation includes volume and appearance of aspirate, drug administered (including lot and amount), any discarded medication noted with applicable modifier, patient tolerance, and post-procedure instructions. Billing is submitted using 20610 for the arthrocentesis/aspiration and/or injection of a major joint or bursa.
Common modifiers and use cases:
-
RT: Use when the procedure is performed on the right-sided joint (site-specific modifier for unilateral procedure). -
LT: Use when the procedure is performed on the left-sided joint (site-specific modifier for unilateral procedure). -
50: Use when the same procedure is performed bilaterally during the same encounter; indicate bilateral service. -
EJ: Use to report a subsequent injection in a series when payer guidelines require a modifier to indicate follow-up injections. -
JW: Use to report discarded amount of a drug or biological from a single-use vial when a portion of the vial is unused and discarded. -
JZ: Use to indicate that there was no remaining drug or biological from a single-use vial (no discarded amount). -
25: Use to indicate a significant, separately identifiable evaluation and management (E/M) service on the same day as the procedure when documentation supports a distinct E/M above what is necessary for the procedure.
Associated provider taxonomies and specialties:
-
207X00000X: Orthopaedic Surgery — physicians specializing in surgical and non-surgical care of the musculoskeletal system. -
207XX0005X: Sports Medicine (Orthopaedic Surgery) — orthopaedic surgeons with additional focus on sports-related musculoskeletal conditions. -
207R00000X: Internal Medicine Physician — physicians providing non-surgical medical management including joint injections in some settings. -
207Q00000X: Family Medicine Physician — primary care physicians who may perform office-based arthrocentesis and injections. -
207P00000X: Emergency Medicine Physician — physicians providing urgent joint aspiration and injection in emergency care settings.
Provided ICD-10 diagnoses:
-
M17.0- Bilateral primary osteoarthritis of kneeClinical relevance: Bilateral degenerative joint disease can produce effusions and pain in both knees, making arthrocentesis and intra-articular injections appropriate for diagnosis, symptom relief, and therapeutic management.
-
M17.11- Unilateral primary osteoarthritis, right kneeClinical relevance: Degeneration localized to the right knee may lead to joint effusion, pain, and functional limitation;
20610is applicable when aspiration or injection is performed on the right knee (RTmodifier as appropriate). -
M17.12- Unilateral primary osteoarthritis, left kneeClinical relevance: Degeneration localized to the left knee may lead to indication for aspiration or injection of the left knee (
LTmodifier as appropriate).
Related CPT codes provided:
20611- Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); with ultrasound guidance, with permanent recording and reporting
Relation to 20610 and clinical workflow:
20611is the ultrasound-guided variant of20610and is billed when real-time ultrasound guidance with permanent recording and reporting is used to aid needle placement into the major joint or bursa. It is used as an alternative to20610when imaging guidance is documented. These codes are commonly used as alternatives depending on whether ultrasound guidance is performed; they are not reported together for the same single injection procedure.
National Reimbursement Benchmarks
National commercial mean rates for CPT 20610 (BUCA as the aggregate commercial benchmark) are higher than Medicare. BUCA’s mean of $82.30 exceeds Medicare’s mean of $70.72, and commercial payers such as Cigna ($98.28) and UnitedHealth Group ($102.68) report substantially higher means than Medicare.
Rate dispersion measured by the interquartile spread (P75 − P25) varies across payers. UnitedHealth Group and Cigna show the widest dispersion (UHC: 56.43, Cigna: 53.40), indicating broader variability in allowed amounts; Aetna and Medicare are among the tightest (Aetna: 41.07, Medicare: 7.00). The table and chart below present the full percentile and mean-rate breakdown by payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.